WhiteLab Genomics logo

WhiteLab GenomicsUnleashing the potential of DNA and RNA based therapies using AI

We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.

2022-02-11
Active
Early
W22
25
Healthcare
FranceUnited States of AmericaEuropeAmerica / CanadaRemotePartly Remote
WhiteLab Genomics screenshot
More About WhiteLab Genomics

WhiteLab Genomics | AI Software Solutions for Gene and Cell Therapy

Accelerated Discovery and Developments with Machine Learning

WhiteLab Genomics leverages graph knowledge technology and machine learning to help customers discover and design new genomic therapies. Our proprietary platform provides in-silico simulations to optimize payloads and vectors, based on exhaustive datasets.

Key Features

  • Graph knowledge technology
  • Machine learning algorithms
  • In-silico simulations
  • Proprietary database
  • Optimized payload and vector design
  • Genotoxicity assessment
  • Experimental protocol identification

Use Cases

  • Gene Therapy: Introduce functional genes to correct genetic disorders.
  • RNA Therapy: Trigger protein synthesis or suppress pathological protein pathways.
  • Cell Therapy: Inject or implant viable cells to trigger medicinal effects.

Pricing

Our technology enables scientists to reduce the development time of biotherapies, making them more accessible and affordable. Some biotherapies can cost up to $1 million, but our solutions aim to lower these costs significantly.

Teams

By combining computer science and biology, WhiteLab Genomics helps customers develop genomic medicines faster and more efficiently, making revolutionary drugs more accessible to patients in need. Our specialized AI platform is designed for DNA and RNA therapies, providing precise and exhaustive answers to key scientific and technological questions.